“Faster-acting drugs have a higher abuse potential,” said DiFeliceantonio. “They have a different impact on the brain. So if ...

Surprised researchers discover hormone-sensitive lipase in the nuclei of fat cells, part of a finely tuned system that ...

“The American public is highly aware that obesity is medically treatable and that reducing it will also save people from a ...

Novo Nordisk said on Tuesday its experimental obesity drug, amycretin, showed statistically significant weight loss of up to ...

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

Waist measurement offers a better health check than BMI. It reveals visceral fat, linked to diabetes and heart issues. For ...

Obesity is one of the most common and complex chronic diseases clinicians encounter in practice. Yet it is still often ...

Discover why Rhythm Pharmaceuticals, Inc. earns a strong buy as IMCIVREE expands in rare obesity markets. Click for this ...

Increasingly, telehealth platforms are positioning blockbuster weight-loss shots not as medicines to treat obesity or diabetes but as cosmetic elixirs for anyone who wants to lose a few pounds.

New research shows that young adults with obesity already display biological patterns associated with liver stress, chronic inflammation, and early neural injury—changes typically seen in older adults ...

Novo Nordisk Pakistan, a multinational pharmaceutical company working in the diabetes and obesity space in Pakistan, states ...

Background: In January, Greystar was named as a defendant in an antitrust lawsuit filed by California Attorney General Rob ...